CD200 and neoplasm: Our results demonstrate the potential utility of activating CD8 cell infiltration in the tumor microenvironment of PDAC, inhibiting FAP and its mechanisms, and blockade of CD200, as well as the potential of each of these proteins in companion diagnostics tests for immunotherapy treatments.